,0
zip,94404
sector,Healthcare
fullTimeEmployees,14400
longBusinessSummary,"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."
city,Foster City
phone,650 574 3000
state,CA
country,United States
companyOfficers,[]
website,https://www.gilead.com
maxAge,1
address1,333 Lakeside Drive
fax,650 522 5853
industry,Drug Manufacturersâ€”General
ebitdaMargins,0.48416
profitMargins,0.22798
grossMargins,0.79762
operatingCashflow,11384000512
revenueGrowth,-0.024
operatingMargins,0.40908
ebitda,13219999744
targetLowPrice,56
recommendationKey,buy
grossProfits,21779000000
freeCashflow,9932624896
targetMedianPrice,72
currentPrice,58.91
earningsGrowth,-0.757
currentRatio,1.272
returnOnAssets,0.102390006
numberOfAnalystOpinions,25
targetMeanPrice,72.34
debtToEquity,126.733
returnOnEquity,0.31569
targetHighPrice,90
totalCash,7405000192
totalDebt,26695000064
totalRevenue,27305000960
totalCashPerShare,5.906
financialCurrency,USD
revenuePerShare,21.74
quickRatio,1.025
recommendationMean,2.5
exchange,NMS
shortName,"Gilead Sciences, Inc."
longName,"Gilead Sciences, Inc."
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,False
gmtOffSetMilliseconds,-14400000
quoteType,EQUITY
symbol,GILD
messageBoardId,finmb_29002
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,3.412
beta3Year,
enterpriseToEbitda,7.046
52WeekChange,-0.109986424
morningStarRiskRating,
forwardEps,6.49
revenueQuarterlyGrowth,
sharesOutstanding,1253890048
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,16.801
sharesShort,14844474
sharesPercentSharesOut,0.0117999995
fundFamily,
lastFiscalYearEnd,1640908800
heldPercentInstitutions,0.83204
netIncomeToCommon,6224999936
trailingEps,4.93
lastDividendValue,0.73
SandP52WeekChange,0.14403355
priceToBook,3.5063388
heldPercentInsiders,0.00095
nextFiscalYearEnd,1703980800
yield,
mostRecentQuarter,1640908800
shortRatio,1.13
sharesShortPreviousMonthDate,1644883200
floatShares,1252570143
beta,0.424212
enterpriseValue,93151469568
priceHint,2
threeYearAverageReturn,
lastSplitDate,1359331200
lastSplitFactor,2:1
legalType,
lastDividendDate,1647216000
morningStarOverallRating,
earningsQuarterlyGrowth,-0.754
priceToSalesTrailing12Months,2.705243
dateShortInterest,1647302400
pegRatio,-13.32
ytdReturn,
forwardPE,9.077042
lastCapGain,
shortPercentOfFloat,0.0117999995
sharesShortPriorMonth,22235510
impliedSharesOutstanding,0
category,
fiveYearAverageReturn,
previousClose,59.14
regularMarketOpen,59.18
twoHundredDayAverage,67.87725
trailingAnnualDividendYield,0.048021644
payoutRatio,0.5761
volume24Hr,
regularMarketDayHigh,59.435
navPrice,
averageDailyVolume10Day,11114630
regularMarketPreviousClose,59.14
fiftyDayAverage,62.9568
trailingAnnualDividendRate,2.84
open,59.18
toCurrency,
averageVolume10days,11114630
expireDate,
algorithm,
dividendRate,2.92
exDividendDate,1647216000
circulatingSupply,
startDate,
regularMarketDayLow,58.8
currency,USD
trailingPE,11.94929
regularMarketVolume,9332969
lastMarket,
maxSupply,
openInterest,
marketCap,73866665984
volumeAllCurrencies,
strikePrice,
averageVolume,11021769
dayLow,58.8
ask,59
askSize,1400
volume,9332969
fiftyTwoWeekHigh,74.12
fromCurrency,
fiveYearAvgDividendYield,3.53
fiftyTwoWeekLow,57.19
bid,58.91
tradeable,False
dividendYield,0.0494
bidSize,800
dayHigh,59.435
regularMarketPrice,58.91
preMarketPrice,
logo_url,https://logo.clearbit.com/gilead.com
